Case Report
J Rheum Dis 2014; 21(5): 274-277
Published online October 30, 2014
© Korean College of Rheumatology
강직성 척추염에서 Infliximab 사용 후 발생한 건선 1예
김민정ㆍ이지현ㆍ임호준ㆍ여현정ㆍ이홍직ㆍ변기섭
메리놀병원 류마티스내과
A Case of Infliximab-induced Psoriasis in Treatment of Ankylosing Spondylitis
Correspondence to : Ji Hyun Lee
Infliximab, which is indicated for refractory rheumatoid arthritis (RA), ankylosing spondylitis (AS) and Crohn’s disease, has cutaneous adverse events including skin rash, urticaria, pruritus, and lupus-like eruption. Psoriasis in-duced by infliximab is very rare. In Korea, it is in-frequently reported in Crohn’s disease or RA and never reported in AS. We encountered a case of psoriasis induced by infliximab treatment for AS, and report here on this case along with a review of the relevant literature.
Keywords Infliximab, Psoriasis, Ankylosing spondylitis
PDF
Standard view
Export citation
Share Article
Case Report
J Rheum Dis 2014; 21(5): 274-277
Published online October 30, 2014
Copyright © Korean College of Rheumatology.
강직성 척추염에서 Infliximab 사용 후 발생한 건선 1예
김민정ㆍ이지현ㆍ임호준ㆍ여현정ㆍ이홍직ㆍ변기섭
메리놀병원 류마티스내과
A Case of Infliximab-induced Psoriasis in Treatment of Ankylosing Spondylitis
Min Jeong Kim, Ji Hyun Lee, Ho Joon Im, Hyun Jung Yeo, Hong Jik Lee, Ki Sup Byun
Division of Rheumatology, Department of Internal Medicine, Maryknoll Medical Center, Busan, Korea
Correspondence to:Ji Hyun Lee
Abstract
Infliximab, which is indicated for refractory rheumatoid arthritis (RA), ankylosing spondylitis (AS) and Crohn’s disease, has cutaneous adverse events including skin rash, urticaria, pruritus, and lupus-like eruption. Psoriasis in-duced by infliximab is very rare. In Korea, it is in-frequently reported in Crohn’s disease or RA and never reported in AS. We encountered a case of psoriasis induced by infliximab treatment for AS, and report here on this case along with a review of the relevant literature.
Keywords: Infliximab, Psoriasis, Ankylosing spondylitis
Article Tools
Stats or Metrics
Share this article on
Related articles in JRD
-
Exacerbation of Psoriatic Skin Lesion followed by TNF-Ձ Antagonist Treatment
Ji-Min Oh, Eun-Mi Koh, Hyungjin Kim, Jaejoon Lee, Joong Kyong Ahn, Hoon-Suk Cha, Joo Heung Lee, Kee Taek Jang
The Journal of the Korean Rheumatism Association 2010; 17(2): 200-204 -
Infliximab Therapy in Korean Patients with Ankylosing Spondylitis
Yoo-Hum Baek, M.D., Ji-Youn Youm, M.D., Hak-Hyun Lee, M.D., Tae-Jong Kim, M.D., Sang-Cheol Bae, M.D., Dae-Hyun Yoo, M.D., Tae-Hwan Kim, M.D.
The Journal of the Korean Rheumatism Association 2006; 13(4): 279-284 -
Osteopoikilosis in a young ankylosing spondylitis patient
Vitaly Omelchenko, M.D., Elena Letyagina, M.D., Maxim Korolev, M.D.
J Rheum Dis 2024; 31(4): 253-256
